Evercore ISI Analyst Gives Highlights From Vertex's Orkambi Call
July 05, 2015 at 14:26 PM EDT
In a report published Friday, Evercore ISI analyst Mark Schoenebaum mentioned that the Orkambi approval ROW of Vertex Pharmaceuticals ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.